TITAN PHARMACEUTICALS INC — Form D
TITAN PHARMACEUTICALS INC of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-21. The offering totals $9.7M, of which $9.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-01-21
- Form: D
- Accession: 0001104659-21-006035
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.7M
- Amount sold: $9.7M
- Investors: 7
- Date of first sale: 2021-01-20
- Revenue range: Decline to Disclose
- SEC file number: 021-386912
Issuer
- Name: TITAN PHARMACEUTICALS INC
- CIK: 0000910267
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 400 OYSTER POINT BLVD, SAN FRANCISCO, CA, 94080
- Phone: 6502444990
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Marc Rubin | Director | Denver, CO |
| Marc Rubin | Executive Officer | Denver, CO |
| Katherine Beebe DeVarney | Director | SAN FRANCISCO, CA |
| Katherine Beebe DeVarney | Executive Officer | SAN FRANCISCO, CA |
| James R McNab, Jr. | Director | SAN FRANCISCO, CA |
| Joseph A Akers | Director | SAN FRANCISCO, CA |
| M. David McFarlane | Director | SAN FRANCISCO, CA |
| Sunil Bhonsle | Director | South San Francisco, CA |
| Sunil Bhonsle | Executive Officer | South San Francisco, CA |
| Katherine DeVarney | Director | South San Francisco, CA |
| Katherine DeVarney | Executive Officer | South San Francisco, CA |
| Dane Hallberg | Executive Officer | South San Francisco, CA |
| Rajinder A Kumar | Director | South San Francisco, CA |
| Katherine Beebe | Executive Officer | South San Francisco, CA |
| SCOTT A SMITH | Director | KIRKLAND, WA |
Other filings by this issuer (3)
More